Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19811776 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder
Condition: Panic Disorder
Interventions: Behavioral: Cognitive behavioral therapy;   Drug: D-cycloserine

Study has passed its completion date and status has not been verified in more than two years.